Introduction
Bronchiectasis is a chronic respiratory disease characterized by productive cough that increases the susceptibility of respiratory tract infection owing to abnormal and irreversible dilatation of the bronchi and bronchioles [1] .
An initial pathological event that causes impairment of sputum clearance from the bronchial tree so, there are devastating illness predisposing individuals to recurrent respiratory tract infection [2] .
Although respiratory tract is normally sterile, conditions such as bronchiectasis enable colonization by microorganisms, such as, fungi, yeasts, and nontuberculous mycobacteria (NTM) [1] . NTM, also known as atypical mycobacteria, grow in the natural environment and can be isolated from soil, tap water, dust, and clinical laboratories [3] .
Diagnosis of NTM is made by repeated isolation of the pathogen based on clinical, radiological and microbiological features [2] .
Patients and methods
This observational cohort study was carried out in Chest Department of Menoufia University Hospital between June 2017 and June 2018 on 40 patients with noncystic fibrosis (CF) bronchiectasis aged at least 18 years.
After obtaining approval of the ethics committee of the Menoufia University Review Board, each patient underwent the following:
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(1) Detailed history taking and general and local examination. (2) Radilogical studies: plain chest radiograph (posterior-anterior view) and high-resolution computed tomography (HRCT) of the chest by using Asiton computed tomography (CT) scanner, with 64 channels, scan thickness of 1 mm at 2-3mm intervals, while the patient was in supine position at full end-tidal inspiration. (3) Laboratory investigation included complte blood count (CBC), ESR, liver function tests (LFTs), and renal function tests (RFTs). (4) Spirometry: forced expiratory flow in first second (FEV 1 ), forced vital capacity, FEV 1 /forced vital capacity, and FEF 25-75.
Sputum analysis
Patients were subjected to sputum sample PCR for tuberculous and NTM, and the positive cases underwent another PCR after 2 months. Sputum samples were collected from all patients and were decontaminated. Then the sediments were inoculated and preserved in archives for PCR analysis. PCR procedures included DNA extraction from sputum, DNA amplification, restriction digestion of the product, and DNA sequence of the amplicons using Applied Biosystems. The use of PCR has been demonstrated because it was more accurate and fast, more available in clinical laboratories, more sensitive, and more specific for NTM species differentiation.
Statistical analysis
Data were collected, tabulated, and statistically analyzed by SPSS version 11.0 statistical package (Wasserstein et al., [4] ).
(1) Qualitative data were expressed as number and percentage and analyzed by applying χ 2 -test. (2) Quantitative variables were expressed as mean±SD and analyzed by applying Student t-test for comparison of means of two groups. (3) Level of significance was set as P value less than 0.05.
Results
A total of 40 (21 females and 19 males) patients were included in the study, with mean±SD age of 55.2±6.5 years, mean±SD BMI of 21.4±2.1, and mean±SD height of 163.7±7.3 cm. There were 7.5% of non-CF bronchiectasis cases with NTM (n=3), mycobacterium avium complex (MAC) was the most common mycobacteria (66.6%) and was predominant in NTM group. The age was higher in NTM group (63 years) than compared negative group (54 years).
In this study, the patients with non-CF bronchiectasis and NTM infection were predominantly females, with low BMI, and all were tall. HRCT studies of patients with NTM especially MAC have shown mucous plugging, peripheral nodules, and ectatic changes in bronchi and marked progression and widespread bronchiectasis in CT. No difference was found in consolidation or tree in bud (TIB) pattern between negative and positive groups. Moreover, there are significant differences regarding purulence and FEV 1 .
Discussion
The incidence of lung colonization and infection owing to NTM in patients with CF and non-CF bronchiectasis is increasing worldwide, which may play a role in pathogensis of bronchiectasis [5] . So, the aim of this study is to investigate NTM as a hidden cause of non-CF bronchiectasis.
Recently, there has been an increase in the incidence of NTM infection owing to diagnostic technique advancements, such as HRCT, which is considered a noninvasive method for the diagnosis of bronchiectasis [6] .
In this study, patients were subjected to sputum samples for PCR of NTM, and the positive cases did another PCR after 2 months. Sputum samples were collected from patients and were decontaminated, and then the sediments were inoculated and preserved in archives for PCR analysis. PCR procedures included DNA extraction from sputum, DNA amplification, restriction digestion of the product, and DNA sequence of the amplicons using Applied Biosystems (Genetic Analyzer and sequencing system, Pharmacuabiotech, Freiburg, Germany).
The use of PCR has been demonstrated because it was more accurate and fast, more available in clinical laboratories, more sensitive, and more specific for differentiation of NTM species, which is in agreement with Garima et al. [7] , who used PCR in their study and Bensi et al. [8] , who used also the same technique.
On the contrary, the method used in the studies by Mirsaeidi et al. [6] and Faverio et al. [9] was sputum culture, which was more suitable for greater number of samples.
In this study, all patients were PCR negative for TB, and this was owing to exclusion of active TB from the study. Moreover, there were 37 (92.5%) patients negative for NTM and three (7.5%) patients positive for NTM (Table 1) .
This was consistent with previous published studies, such as David et al. [10] , who studied NTM in bronchiectasis and found that 13% of patients with bronchiectasis were positive for NTM.
Faverio et al. [9] studied NTM infection in bronchiectasis and found that 12% of all patients with bronchiectasis had NTM.
Moreover, Wickremasinghe et al. [11] reported that NTM was found in 6% of patients with bronchiectasis.
Another study by Maiz et al. [12] studied the prevalence and factors associated with NTM in bronchiectasis and found that the incidence of NTM was 9.3% in patients with bronchiectasis.
On the contrary, a study by Mirsaeidi et al. [6] found that 37% of patients were positive for NTM.
In this study, the most common species of positive patients for NTM was MAC (66.66%) ( Table 2) , and the percentage was consistent with the other previous published studies such as David et al. [10] , who reported that 72% of positive patients for NTM were MAC, and Faverio et al. [9] , who found that 70% of positive patients for NTM were MAC.
Another study by Wickremasinghe et al. [11] found that 84% of positive patients for NTM were MAC.
In this study, PCR was performed for 40 patients with age ranging 42-67 years, and there were significant differences between the negative patients, with mean age of 54.7 years, and positive patients, with mean age of 63.3 years, which means that the incidence of NTM increased with the increase of age.
This was explained by the fact elderly people were more at risk as their immunity was more suppressed.
This result was consistent with Maiz et al. [12] who reported that the mean age at identification of NTM was 64.5 years, and their explanation of it was owing to primary alteration of immune response in older patients.
Fowler et al. [5] , Mirsaeidi et al. [6] , Faverio et al. [9] and Wickremasinghe et al. [11] , reported that the mean age at identification of NTM was 64.5 years.
In this study, the highest percentage of positive patients was represented by females (67%) and males represented 33%, with significant difference ( Table 3 ). This result was consistent with Mirsaeidi et al. [6] who found that 68% of positive patients for NTM were females, and their explanation was because of the menopausal status as estrogen plays a protective role, especially against MAC, and also the usage of anabolic steroid may play role and maybe there is a genetic resistance in males. Moreover, Faverio et al. [9] found that 59% of positive patients for NTM were females. Maiz et al. [12] found that 78% of positive patients for NTM were females. Fowler et al. [5] found that 66% of positive patients for NTM were females.
In this study, BMI range was 17-26, and the mean BMI of the negative patients was 18-26, and for the positive patients was lower at 17-18, with significant difference (Table 4 ). This may be explained by repeated chest infection in patients with bronchiectasis, and associated comorbidities was the cause of weight loss.
This result was consistent with Maiz et al. [12] , who reported that the mean BMI was less than 23 in more than 61% of positive patients for NTM. David et al. (9) reported that the mean BMI was significantly lower in positive cases, and their explanation was this population did have higher rates of silicosis, pectus excavtum, and mitral valve prolapsed compared with matched group.
Faverio et al. [9] reported that the mean BMI in their study was 20.
In this study, the height range of negative patients for NTM was 154-174 cm and the height of positive patients for NTM was 180-188, with significant difference ( Table 5 ).
This was explained by the fact that some congenital anomalies, such as Marfan syndrome, causing bronchiectasis was common in tall individuals.This study was consistent with David et al. [10] , who found that height was significantly greater in NTM positive patients
In this study, regarding CT chest, there were some common features for the most positive patients including signet ring appearance, TIB, nodular pattern, and cylindrical pattern (Tables 6  and 7 ). This result was agreed with Faverio et al. [9] who found that most positive patients had nodular and cylindrical pattern in CT. Moreover, David et al. [10] reported that the common CT features in positive patients for NTM in their study were TIB and nodular pattern. Fowler et al. [5] who found that most positive patients had bronchial thickening, mucous plugging(signet ring) and TIB in CT. Wickremasinghe et al. [11] found that most positive patients had nodules, mucous plugging, and small cavities in the HRCT.
In this study, the sputum purulence was less in patients positive for NTM (Table 8 ) and this was explained by the fact that the general conditions of the positive patients for NTM were better than the negative patients. This result was agreed with Maiz et al. [12] , who found that the sputum purulence was less in patients positive for NTM. From this study, the following could be concluded:
(1) NTM is a hidden cause of non-CF bronchiectasis .
(2) MAC is the most frequent NTM in these patients. (3) Female patients with a low BMI are a high risk group for NTM infection in bronchiectasis. (4) HRCT finding is nodular pattern and TIB.
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